Dalan, Maribel R.
HRN: 03-01-01 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/15/2023
CEFTRIAXONE 1G (VIAL)
06/15/2023
06/21/2023
IV
2g
Od
Wbc 39.6, T/c UTI, T/c Leprosy
Waiting Final Action
Indication: Empiric Type of Infection: Urinary Tract Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes